Sex differences in circulating inflammatory mediators as a function of substance use disorder

Area of Science:

• Neuroscience
• Psychiatry
• Immunology

Background:

• Comorbid substance use disorders (SUD) and depression/anxiety negatively impact treatment outcomes.
• Elevated inflammation (e.g., IL-6, CRP) is observed in some depressed individuals.
• Limited research explores if SUD exacerbates inflammation.

Purpose of the Study:

• To investigate the association between SUD and blood-based inflammation markers.
• To examine sex-specific differences in inflammation profiles related to SUD.
• To explore the relationship between emotional processing, SUD, and inflammation.

Main Methods:

• Recruited 160 treatment-seeking individuals with major depressive disorder (MDD), anxiety disorders, and/or SUD.
• Collected blood samples for inflammatory biomarker analysis (IL-6, IL-8, IL-10, TNF-α, CRP).
• Utilized principal component analysis (PCA) on questionnaire data to identify emotionality factors and analyzed their association with SUD and inflammation, controlling for covariates.

Main Results:

• Females with SUD showed higher IL-8 and IL-10, and lower CRP compared to females without SUD.
• No significant association between SUD and biomarker levels was found in males.
• Higher BMI correlated with increased IL-6 and CRP across sexes; IL-6 and CRP showed shared variance.

Conclusions:

• Findings reveal sex-specific inflammatory profiles associated with SUD.
• These sex-specific patterns may offer novel targets for therapeutic interventions.
• Further research is warranted to elucidate the mechanisms underlying these differences.